NCT00288067 2014-10-06Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1/2 Terminated32 enrolled 7 charts
NCT00075491 2013-01-24Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma MultiformeNational Cancer Institute (NCI)Phase 2 Terminated42 enrolled